Close

More on TRVI

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-18.2% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (5/8/25)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Trevi Therapeutics (NQ:TRVI)
Delayed: 6.07 -0.03 (0.49%)
Prev. Close $6.10  
Open$6.08 
52 Wk High$ 
52 Wk Low$ 
Day High$6.39 
Day Low$5.94 
P/E N/A  
EPS$ 
Volume710,037 


Apr 3, 2025 07:30 AM Trevi Therapeutics to Participate in Upcoming April Investor Conferences
Mar 26, 2025 04:30 PM Form 4 Trevi Therapeutics, Inc. For: Mar 25 Filed by: SCIASCIA THOMAS
Mar 26, 2025 07:02 AM Avalo Therapuetics (AVTX) Appoints Michael Heffernan as Chairman of the Board
Mar 26, 2025 07:00 AM Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
Mar 25, 2025 04:30 PM Form 4 Trevi Therapeutics, Inc. For: Mar 21 Filed by: GOOD JENNIFER L
Mar 21, 2025 04:14 PM Form 144 Trevi Therapeutics, Inc. Filed by: GOOD JENNIFER L
Mar 20, 2025 07:55 PM Form SCHEDULE 13D/A Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P.
Mar 19, 2025 08:26 AM Trevi Therapeutics (TRVI) PT Raised to $20 at B.Riley
Mar 19, 2025 07:22 AM Raymond James Reiterates Strong Buy Rating on Trevi Therapeutics (TRVI)
Mar 19, 2025 07:13 AM Stifel Reiterates Buy Rating on Trevi Therapeutics (TRVI)
View All Articles

Entities mentioned with TRVI

View All Entities